vs
Kiniksa Pharmaceuticals International, plc（KNSA）与Revolve Group, Inc.（RVLV）财务数据对比。点击上方公司名可切换其他公司
Revolve Group, Inc.的季度营收约是Kiniksa Pharmaceuticals International, plc的1.6倍（$324.4M vs $202.1M），Kiniksa Pharmaceuticals International, plc净利率更高（7.0% vs 5.7%，领先1.3%），Kiniksa Pharmaceuticals International, plc同比增速更快（65.0% vs 10.4%），Kiniksa Pharmaceuticals International, plc自由现金流更多（$53.3M vs $-13.3M），过去两年Kiniksa Pharmaceuticals International, plc的营收复合增速更高（59.1% vs 9.5%）
Kiniksa Pharmaceuticals International plc是一家全球性生物制药企业，专注于发现、开发和商业化针对自身免疫性疾病、炎症性疾病及罕见病的靶向治疗药物，服务北美、欧洲、亚洲等主要市场的未被满足的临床需求。
Revolve Theatre Company是总部位于英国泰晤士河畔亨利的剧团，专注于创作演出政治题材和莎士比亚系列戏剧作品，由奥利弗·登奇、乔·莫里斯与汤姆·史密斯共同创立运营。
KNSA vs RVLV — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $202.1M | $324.4M |
| 净利润 | $14.2M | $18.6M |
| 毛利率 | 89.6% | 53.3% |
| 营业利润率 | 9.8% | 6.3% |
| 净利率 | 7.0% | 5.7% |
| 营收同比 | 65.0% | 10.4% |
| 净利润同比 | 259.8% | 50.4% |
| 每股收益（稀释后） | $0.18 | $0.27 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $202.1M | $324.4M | ||
| Q3 25 | $180.9M | $295.6M | ||
| Q2 25 | $156.8M | $309.0M | ||
| Q1 25 | $137.8M | $296.7M | ||
| Q4 24 | $122.5M | $293.7M | ||
| Q3 24 | $112.2M | $283.1M | ||
| Q2 24 | $108.6M | $282.5M | ||
| Q1 24 | $79.9M | $270.6M |
| Q4 25 | $14.2M | $18.6M | ||
| Q3 25 | $18.4M | $21.2M | ||
| Q2 25 | $17.8M | $10.2M | ||
| Q1 25 | $8.5M | $11.8M | ||
| Q4 24 | $-8.9M | $12.3M | ||
| Q3 24 | $-12.7M | $11.0M | ||
| Q2 24 | $-3.9M | $15.4M | ||
| Q1 24 | $-17.7M | $10.9M |
| Q4 25 | 89.6% | 53.3% | ||
| Q3 25 | 88.8% | 54.6% | ||
| Q2 25 | 88.1% | 54.1% | ||
| Q1 25 | 87.0% | 52.0% | ||
| Q4 24 | 85.4% | 52.5% | ||
| Q3 24 | 82.1% | 51.2% | ||
| Q2 24 | 88.7% | 54.0% | ||
| Q1 24 | 86.7% | 52.3% |
| Q4 25 | 9.8% | 6.3% | ||
| Q3 25 | 13.3% | 7.1% | ||
| Q2 25 | 12.9% | 5.8% | ||
| Q1 25 | 9.6% | 5.0% | ||
| Q4 24 | -15.7% | 3.9% | ||
| Q3 24 | -8.6% | 5.0% | ||
| Q2 24 | -0.1% | 5.8% | ||
| Q1 24 | -20.7% | 3.4% |
| Q4 25 | 7.0% | 5.7% | ||
| Q3 25 | 10.2% | 7.2% | ||
| Q2 25 | 11.4% | 3.3% | ||
| Q1 25 | 6.2% | 4.0% | ||
| Q4 24 | -7.3% | 4.2% | ||
| Q3 24 | -11.3% | 3.9% | ||
| Q2 24 | -3.6% | 5.4% | ||
| Q1 24 | -22.2% | 4.0% |
| Q4 25 | $0.18 | $0.27 | ||
| Q3 25 | $0.23 | $0.29 | ||
| Q2 25 | $0.23 | $0.14 | ||
| Q1 25 | $0.11 | $0.16 | ||
| Q4 24 | $-0.11 | $0.18 | ||
| Q3 24 | $-0.18 | $0.15 | ||
| Q2 24 | $-0.06 | $0.21 | ||
| Q1 24 | $-0.25 | $0.15 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $414.1M | $292.3M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $567.6M | $512.5M |
| 总资产 | $763.6M | $765.0M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q4 25 | $414.1M | $292.3M | ||
| Q3 25 | $352.1M | $315.4M | ||
| Q2 25 | $307.8M | $310.7M | ||
| Q1 25 | $268.3M | $300.8M | ||
| Q4 24 | $243.6M | $256.6M | ||
| Q3 24 | $223.8M | $252.8M | ||
| Q2 24 | $218.8M | $244.7M | ||
| Q1 24 | $213.6M | $273.4M |
| Q4 25 | $567.6M | $512.5M | ||
| Q3 25 | $535.4M | $490.2M | ||
| Q2 25 | $495.0M | $468.6M | ||
| Q1 25 | $457.5M | $453.4M | ||
| Q4 24 | $438.4M | $437.8M | ||
| Q3 24 | $437.0M | $420.8M | ||
| Q2 24 | $435.1M | $405.8M | ||
| Q1 24 | $431.9M | $389.9M |
| Q4 25 | $763.6M | $765.0M | ||
| Q3 25 | $712.3M | $751.3M | ||
| Q2 25 | $661.1M | $722.9M | ||
| Q1 25 | $599.3M | $713.9M | ||
| Q4 24 | $580.6M | $665.5M | ||
| Q3 24 | $555.3M | $670.9M | ||
| Q2 24 | $542.4M | $657.8M | ||
| Q1 24 | $519.7M | $650.0M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $53.9M | $-10.2M |
| 自由现金流经营现金流 - 资本支出 | $53.3M | $-13.3M |
| 自由现金流率自由现金流/营收 | 26.4% | -4.1% |
| 资本支出强度资本支出/营收 | 0.3% | 1.0% |
| 现金转化率经营现金流/净利润 | 3.80× | -0.55× |
| 过去12个月自由现金流最近4个季度 | $136.4M | $48.0M |
8季度趋势，按日历期对齐
| Q4 25 | $53.9M | $-10.2M | ||
| Q3 25 | $33.7M | $11.8M | ||
| Q2 25 | $28.1M | $12.6M | ||
| Q1 25 | $22.3M | $45.1M | ||
| Q4 24 | $18.8M | $3.9M | ||
| Q3 24 | $-2.2M | $9.1M | ||
| Q2 24 | $5.2M | $-24.7M | ||
| Q1 24 | $4.0M | $38.4M |
| Q4 25 | $53.3M | $-13.3M | ||
| Q3 25 | $33.0M | $7.5M | ||
| Q2 25 | $27.9M | $10.4M | ||
| Q1 25 | $22.2M | $43.4M | ||
| Q4 24 | $18.6M | $2.1M | ||
| Q3 24 | — | $8.0M | ||
| Q2 24 | — | $-25.7M | ||
| Q1 24 | $3.9M | $36.7M |
| Q4 25 | 26.4% | -4.1% | ||
| Q3 25 | 18.2% | 2.5% | ||
| Q2 25 | 17.8% | 3.4% | ||
| Q1 25 | 16.1% | 14.6% | ||
| Q4 24 | 15.2% | 0.7% | ||
| Q3 24 | — | 2.8% | ||
| Q2 24 | — | -9.1% | ||
| Q1 24 | 4.9% | 13.5% |
| Q4 25 | 0.3% | 1.0% | ||
| Q3 25 | 0.4% | 1.5% | ||
| Q2 25 | 0.1% | 0.7% | ||
| Q1 25 | 0.1% | 0.6% | ||
| Q4 24 | 0.2% | 0.6% | ||
| Q3 24 | 0.0% | 0.4% | ||
| Q2 24 | 0.0% | 0.4% | ||
| Q1 24 | 0.1% | 0.6% |
| Q4 25 | 3.80× | -0.55× | ||
| Q3 25 | 1.83× | 0.56× | ||
| Q2 25 | 1.58× | 1.24× | ||
| Q1 25 | 2.61× | 3.82× | ||
| Q4 24 | — | 0.32× | ||
| Q3 24 | — | 0.83× | ||
| Q2 24 | — | -1.60× | ||
| Q1 24 | — | 3.53× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
KNSA
暂无分部数据
RVLV
| Fashion Apparel | $155.1M | 48% |
| Dresses | $76.4M | 24% |
| Handbags Shoes And Accessories | $67.6M | 21% |
| Beauty | $20.3M | 6% |
| Manufactured Product Other | $5.0M | 2% |
| Breakage On Store Credit And Gift Cards | $900.0K | 0% |
